WATERMARK: Pharmaceutical, Biotech and Med Devices Safety Oversight

Home

WATERMARK DSMB

Critical Independence

Committee Composition

Data Administration

Regulatory Audits

Adjudication Panels

WATERMARK Advantage

Post-Market Safety

Patient Outcomes Registry

Collect Independent Data

Device Safety

Articles/Press Releases

Corporate Overview

WATERMARK Contact

WATERMARK Communications

DSMB extranet access

DSMB, IDMC, Adjudication Panels, Post-Market Safety, Outcome Registries.

Committee Composition 
We can establish a DSMB for your project or help manage an existing board.  We work to provide you with a list of potential board members based on therapeutic expertise and clinical trial experience.  The ability of the board members to understand clinical trials and have a therapeutic expertise is paramount to the board’s efficiency and the review of data. WATERMARK has extensive experience providing services to data and safety monitoring boards.  We provide all the forms needed for FDA compliance including the disclosure forms, open and closed meeting minute templates, and board charter.     

     Committee Independence

The board and all members must be independent of the study and product in question in all regards including:           
•        research participation 
         
•        financial interests
         
•        supportive activities
  
 

We ensure that all board members complete and sign financial disclosures as well as disclosure of speaking or other consulting activities.  These disclosures help document and ensure there is no conflict of interest in review of your data.  All information on board members are updated yearly to ensure the most accurate information is available.

Powered by Watermark Research Partners, 2009
copyright, all rights reserved.